Accepting New Patients
Amir A. Razmjou, MD, MS
(he/him)
- Rheumatology
Westwood Specialty Care
|
200 Medical Plaza, Suite 365, Los Angeles, CA 90095
US
About
Dr. Razmjou has a clinical and research interest in seeing patients with Rheumatoid Arthritis (RA), RA-Interstitial Lung Disease, and Spondyloarthritis (SpA)- including Axial Spondyloarthritis/Ankylosing Spondylitis. He is dual-appointmented at both UCLA Health, and the Greater Los Angeles VA and spends time seeing patients in clinic, inpatient consultations, teaching/training, and research.
Languages
Education
Medical Board Certifications
Rheumatology, American Board of Internal Medicine, 2023
Internal Medicine, American Board of Internal Medicine, 2020
Fellowship
Rheumatology, UCLA David Geffen School of Medicine, 2023
Residency
Internal Medicine, UCLA School of Medicine, 2020
Degrees
MS, UCLA Health, 2023
MD, Medical College of Wisconsin, 2017
Recognitions
- Super Doctors® Southern California Rising Stars 2025
Locations
Hospital Affiliations
Ronald Reagan UCLA Medical Center
Areas of Focus
Research
Interests
- Rheumatoid Arthritis
- Rheumatoid Arthritis Interstitial Lung Disease
- Spondyloarthritis (Ankylosing Spondylitis, Psoriatic Arthritis, IBD-Arthritis)
Publications
- Razmjou AA, Wang JM, Shahbazian A, Reddy S, Charles-Schoeman C. Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis. Clin Rheumatol. 2023 Jan;42(1):75-82. doi: 10.1007/s10067-022-06375-w. Epub 2022 Sep 22. Erratum in: Clin Rheumatol. 2023 Nov;42(11):3175. PMID: 36138190; PMCID: PMC9823017.
- Razmjou AA, Brook J, Elashoff D, Kaeley G, Choi S, Kermani T, Ranganath VK. Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis. BMC Rheumatol. 2020 Oct 19;4:55. doi: 10.1186/s41927-020-00153-4. PMID: 33089069; PMCID: PMC7569763.
- Razmjou, AA, et al. Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins. RMD Open. 2024, Oct 26;10(4):e004829.
- Razmjou, AA, Pham, A, Volkman, ER, Ranganath, VK. Survival after lung transplantation in patients with rheumatoid arthritis-associated lung disease. J Rheumatol. 2025, Apr 1.
Insurance
- Aetna
- Anthem Blue Cross
- Blue Shield of California
- Centivo
- Cigna
- First Health
- Health Net of California
- Interplan (part of HealthSmart)
- Medicare Advantage
- MultiPlan
- UFCM Health System
- Prime Health Services
- Private Healthcare Systems (PHCS)
- TRICARE
- UnitedHealthcare
The list of health care plans above may not be comprehensive and could change.
Please contact your benefits coordinator or health insurance company directly to verify coverage.
Visit our health insurance information page for more details.
Recognitions
- Super Doctors® Southern California Rising Stars 2025